Search - tctmd.com

Displaying 641 - 660 of 671

Sort: Relevancy | Date

Presentation

Insuficiente Inhibición Plaquetaria asociada a Infartos Cerebrales Embólicos Silenciosos tras Angiografía

Presenter: B.J. Kim

January 12, 2012

Presentation

Insufficient Platelet Inhibition Related to Silent Embolic Cerebral Infarctions After Angiography

Presenter: B.J. Kim

January 12, 2012

Presentation

Relación del Dabigatran con un Mayor Riesgo de Episodios Coronarios Agudos

Presenter: Ken Uchino

January 09, 2012

Presentation

Dabigatran Association with Higher Risk of Acute Coronary Events

Presenter: Ken Uchino

January 09, 2012

Presentation

CYP2C19 Genotype, Clopidogrel Metabolism, Platelet Function, and Cardiovascular Events

Presenter: Michael V. Holmes

January 04, 2012

Presentation TCT 2012

Ticagrelor Enhances Adenosine-induced Coronary Vasodilatory Responses in Humans—a Randomised, Double-Blind, Placebo-Controlled, Crossover, Single Centre Study Using...

Presenter: Li-Ming Gan, Ann Wittfeldt, H?kan Emanuelsson, Sven Nylander, Magnus Andersson

January 03, 2012

Presentation TCT 2012

The Effect Of Cilostazol On The Antiplatelet Efficacy Of Patients with Moderate Renal Dysfunction: Post-hoc Analysis Of CILON-T (Influence of CILostazol based triple...

Presenter: Min-Ho Lee, Jung-Won Suh, Seung-Pyo Lee, Kyung Woo Park, Hae-Young Lee, Hyun-Jae Kang, Bon-Kwon Koo, Young-Seok Cho, Tae-Jin Youn, In-Ho Chae, Dong-Ju Choi, Seung-Woon Rha, Jang-Ho Bae, Taek-Geun Kwon, Jang-Whan Bae, Myeong-Chan Cho, Hyo-Soo Kim

January 03, 2012

Presentation TCT 2012

The Controlled Reperfusion with Bivalirudin and Intra Coronary Abciximab in the Porcine Mycoardial Infarction/Reperfusion Model

Presenter: Piotr P. Buszman, Wojciech Wojakowski, Krzystof Milewski, Marcin Debinski, Jacek Pajak, Wanda Jackiewicz, Michal Jelonek, Pawel E. Buszman

January 03, 2012

Presentation TCT 2012

Stopping Clopidogrel 1 year After Drug-Eluting Stent (DES) Implantation: Is It Safe?

Presenter: Nalyaka Sambu, Hazel Dent, Timothy Warner, Nicola Englyst, Philip Leadbeater, Alex Hobson, Alison Calver, Simon Corbett, Huon Gray, Iain Simpson, John Morgan, Nick Curzen

January 03, 2012

Presentation TCT 2012

Safety and Efficacy for the Use of Prasugrel in Patients Undergoing Percutaneous Coronary Intervention and Anticoagulated with Bivalirudin.

Presenter: Ana Laynez, Rebecca Torguson, Camille Hauville, Gabriel Sardi, Itsik Ben-Dor, Gabriel Maluenda, Michael A. Gaglia, Manuel A. Gonzalez, Israel M. Barbash, Zhenyi Xue, William O. Suddath, Lowell F. Satler, Kenneth M. Kent, Augusto D. Pichard, Ron Waksman

January 03, 2012

Presentation TCT 2012

Response to Prasugrel in ST Elevation Myocardial Infarction Patients: is it as Rapid as we Expected?

Presenter: Fr?d?ric Casassus, Lionel Leroux, Chloe James, Sali Sidibe, Agnalys Desplantes, David Naibo, Benjamin Seguy, Pierre Chevallereau, Pierre Coste

January 03, 2012

Presentation TCT 2012

Protease Activated Receptor-1 (PAR-1) Mediated Platelet Aggregation is Dependant on Clopidogrel Response

Presenter: Rolf P. Kreutz, David A. Flockhart, Yvonne Kreutz, Jeffrey A. Breall

January 03, 2012

Presentation TCT 2012

Prolonged Bivalirudin Infusion is Associated with Enhanced ST Segment Resolution Following Primary Percutaneous Coronary Intervention

Presenter: Bernardo Cortese, Ugo Limbruno, Sara De Matteis, Livia Diehl, Antonino Pit?

January 03, 2012

Presentation TCT 2012

<b>Pharmacodynamic Effect of Double-dose Clopidogrel versus Adding Dipyridamole In Patients With High On-treatment Platelet Reactivity (ACCEL-DIP) study</b>

Presenter: Yongwhi Park, Young-Hoon Jeong, Jeong-Rang Park, Seok-Jae Hwang, Choong Hwan Kwak, Jin-Yong Hwang

January 03, 2012

Presentation TCT 2012

Paraoxonase-1 (PON1) Activity And PON1 Polymorphisms Have No Effect On Platelet Reactivity In Patients Treated With Clopidogrel

Presenter: Jean-Pierre P. Dery, Abdelouahed Khalil, Ugo D?ry, M?lanie Roy, Pierluigi Tricoci, Richard Becker, Stéphane Rinfret, Éric Larose, G?rald Barbeau, Robert DeLarochelli?re, Josep Rod?s-Cabau, Olivier F. Bertrand

January 03, 2012

Presentation TCT 2012

Methods of measurement of aspirin-mediated antiplatelet. Degree of correlation and agreement between two “point of care: VerifyNow®Aspirin assay and PFA-100®

Presenter: Jose Maria Cubero Gomez, Maria Asunci?n Navarro Puerto, Maria Isabel De Mier Barragan, Francisco J. Sanchez-Burguillos, Pastor L. Perez-Santigosa, Francisco J. Molano Casimiro, Luis F. Pastor Torres

January 03, 2012

Presentation TCT 2012

Long-Term Dual Anti-Platelet Therapy in Patients Treated with Bare Metal Stent Implantation: Results From the NHLBI Dynamic Registry

Presenter: Gopi Manthripragada, Oscar C. Marroquin, Helen Vlachos, Sameer Khandhar, Catalin Toma, Joon S. Lee, David O. Williams, Kevin E. Kip, Suresh Mulukutla

January 03, 2012

Presentation TCT 2012

Inhibition of Platelet Aggregation by Prostaglandin E1 (PGE1) May Be Attenuated in Diabetic Patients During Therapy with Clopidogrel

Presenter: Rolf P. Kreutz, Perry Nystrom, Yvonne Kreutz, Jiao Miao, Richard Kovacs, David Flockhart, Zeruesenay Desta, Yan Jin

January 03, 2012

Presentation TCT 2012

In hospital and 30 day outcomes in all-comer percutaneous coronary intervention with bivalirudin: Initial report of the prospective EUROVISION Registry. Hamon M, Nienaber C,...

Presenter: Martial Hamon

January 03, 2012

Presentation TCT 2012

Genetic Variants Affecting Clopidogrel Metabolism Have Minor Influence on Platelet Reactivity After Elective Percutaneous Coronary Intervention

Presenter: Andr?s Kom?csi, Orsolya Rideg, Gy?ngyv?r K?lt?, Andr?s Vorobcsuk, Daniel Aradi

January 03, 2012

Advertisement

Insuficiente Inhibición Plaquetaria asociada a Infartos Cerebrales Embólicos Silenciosos tras Angiografía

Insufficient Platelet Inhibition Related to Silent Embolic Cerebral Infarctions After Angiography

Relación del Dabigatran con un Mayor Riesgo de Episodios Coronarios Agudos

Dabigatran Association with Higher Risk of Acute Coronary Events

CYP2C19 Genotype, Clopidogrel Metabolism, Platelet Function, and Cardiovascular Events

Ticagrelor Enhances Adenosine-induced Coronary Vasodilatory Responses in Humans—a Randomised, Double-Blind, Placebo-Controlled, Crossover, Single Centre Study Using...

The Effect Of Cilostazol On The Antiplatelet Efficacy Of Patients with Moderate Renal Dysfunction: Post-hoc Analysis Of CILON-T (Influence of CILostazol based triple...

The Controlled Reperfusion with Bivalirudin and Intra Coronary Abciximab in the Porcine Mycoardial Infarction/Reperfusion Model

Stopping Clopidogrel 1 year After Drug-Eluting Stent (DES) Implantation: Is It Safe?

Safety and Efficacy for the Use of Prasugrel in Patients Undergoing Percutaneous Coronary Intervention and Anticoagulated with Bivalirudin.

Response to Prasugrel in ST Elevation Myocardial Infarction Patients: is it as Rapid as we Expected?

Protease Activated Receptor-1 (PAR-1) Mediated Platelet Aggregation is Dependant on Clopidogrel Response

Prolonged Bivalirudin Infusion is Associated with Enhanced ST Segment Resolution Following Primary Percutaneous Coronary Intervention

<b>Pharmacodynamic Effect of Double-dose Clopidogrel versus Adding Dipyridamole In Patients With High On-treatment Platelet Reactivity (ACCEL-DIP) study</b>

Paraoxonase-1 (PON1) Activity And PON1 Polymorphisms Have No Effect On Platelet Reactivity In Patients Treated With Clopidogrel

Methods of measurement of aspirin-mediated antiplatelet. Degree of correlation and agreement between two “point of care: VerifyNow®Aspirin assay and PFA-100®

Long-Term Dual Anti-Platelet Therapy in Patients Treated with Bare Metal Stent Implantation: Results From the NHLBI Dynamic Registry

Inhibition of Platelet Aggregation by Prostaglandin E1 (PGE1) May Be Attenuated in Diabetic Patients During Therapy with Clopidogrel

In hospital and 30 day outcomes in all-comer percutaneous coronary intervention with bivalirudin: Initial report of the prospective EUROVISION Registry. Hamon M, Nienaber C,...

Genetic Variants Affecting Clopidogrel Metabolism Have Minor Influence on Platelet Reactivity After Elective Percutaneous Coronary Intervention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content